U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191704) titled 'A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Famil... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191587) titled 'A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193212) titled 'How Osteopathic Treatment Affects the Leg and Foot in People With Low Back Pain' on Sept. ... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193329) titled 'Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcom... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192172) titled 'Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192094) titled 'A Reinforced Mindfulness-Based Intervention to Reduce Problematic Drinking Among Hispanic ... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191951) titled 'Shanghai Clinical Cohort - Adrenal Disease' on Sept. 17. Brief Summary: As a vital organ ... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192406) titled 'Cross-cultural Adaptation of the Toxic Masculinity Scale Among Indonesian Nursing Students... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191743) titled 'Functional Assessment in Critically Ill Patients' on Aug. 26. Brief Summary: This longitu... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193160) titled 'Sacituzumab Tirumotecan in Combination With Furmonertinib as Second-line Treatment for EGF... Read More